Physician

Kevin Mcmullen, M.D.

According to 2025 Medicare claims, Kevin Mcmullen, M.D. (NPI: 1225442247) practices dermatology in the Missoula, MT market, with the plurality of this provider's patient population coming from Missoula, MT. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1922647395; TIN: 391351587) and primary practice location at 59801-6518. Mcmullen is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mcmullen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,183 traditional Medicare patients, billed 6,540 HCPCS/CPT codes, and received $223,771 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 697 prescription claims across 317 beneficiaries totaling $393,419 in drug costs, led by Otezla (Apremilast). Open Payments data shows 10 records totaling $196. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,471 to $223,771. Similarly, Part D prescription costs have risen steadily, from $2,704 to $393,419. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$135K$271K2019 Medicare payment: $9,471 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $9,420 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $26,398 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $134,551 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $270,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $223,771 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193183$9,471
202038158$9,420
2021127378$26,398
20226032,959$134,551
20231,2398,215$270,740
20241,1836,540$223,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$197K$393K2015 Drug cost: $2,704 (USD; Tot_Drug_Cst)2016 Drug cost: $28,427 (USD; Tot_Drug_Cst)2017 Drug cost: $15,230 (USD; Tot_Drug_Cst)2018 Drug cost: $17,375 (USD; Tot_Drug_Cst)2019 Drug cost: $89,419 (USD; Tot_Drug_Cst)2020 Drug cost: $94,297 (USD; Tot_Drug_Cst)2021 Drug cost: $76,472 (USD; Tot_Drug_Cst)2022 Drug cost: $113,256 (USD; Tot_Drug_Cst)2023 Drug cost: $272,493 (USD; Tot_Drug_Cst)2024 Drug cost: $393,419 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151828$2,704
20161533$28,427
201741132$15,230
201883170$17,375
201954108$89,419
20202877$94,297
202147112$76,472
2022187399$113,256
2023320792$272,493
2024317697$393,419

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth378440$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9311,263$62
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more175200$42
17000Destruction of precancer skin growth, 1 growth699963$42
17003Destruction of precancer skin growth, 2-14 growths5453,101$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast12360$58,800
LitfuloRitlecitinib Tosylate14392$56,339
Clobetasol PropionateClobetasol Propionate701,940$2,910
FluocinonideFluocinonide541,644$1,718
KetoconazoleKetoconazole862,583$1,209

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$196Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Mcmullen, M.D.?

Tedicare shows public-source Medicare data for Kevin Mcmullen, M.D. (NPI 1225442247), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Mcmullen, M.D. have ACO affiliation data?

Kevin Mcmullen, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kevin Mcmullen, M.D.?

Kevin Mcmullen, M.D. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1922647395) in the available physician profile data.

Does Kevin Mcmullen, M.D. have Open Payments data?

Kevin Mcmullen, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.